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Purpose: The purposes of this study were to investigate the effect of hormonal alterations on the expression of caveolin-1 in the 
urinary bladders of ovariectomized rats and to determine the role of caveolin-1 in the overactivity of the detrusor muscle that 
occurs with hormonal alterations in rats.
Methods: Female Sprague-Dawley rats were divided into three groups: a control group, a group that underwent bilateral ovari-
ectomy (Ovx), and a group that underwent bilateral ovariectomy followed by subcutaneous injections of 17β-estradiol (Ovx+ 
Est). After 4 weeks, urodynamic studies were done to measure the contraction interval and contraction pressure. The expression 
and cellular localization of caveolin-1 were determined by Western blot and immunofluorescence in the urinary bladders of rats.
Results: On cystometrograms, the contraction interval was significantly shorter in the Ovx group (3.0±0.3 minute) than in the 
control group (5.6±0.5 minute) but was longer in the Ovx+Est group (9.2±0.4 minute) (P<0.05). Conversely, the average con-
traction pressure was higher in the Ovx group (26.4±0.48 mmHg) than in the control group (21.8±0.37 mmHg) but was lower 
in the Ovx+Est group (23.9±0.76 mmHg) (P<0.05). Caveolin-1 was expressed in the capillaries, arterioles, and venules. Ex-
pression of the protein caveolin-1 was significantly lower after ovariectomy and was restored to control levels after treatment with 
17β-estradiol (P<0.05).
Conclusions: Hormonal alterations cause a significant change in the expression of caveolin-1, which suggests that caveolin-1 
mi  ght have a functional role in the overactivity of the detrusor muscle related to hormonal alterations in the urinary bladders of 
rats.
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INTRODUCTION
Traditionally, the urothelium has been considered to be a sim-
ple passive barrier between the urinary tract and urine. Recent-
ly, however, the role of the urothelium has changed and it is now 
understood to be a responsive organ capable of sensing a vari-
ety of signals from the urinary bladder [1]. Caveolae are small 
invaginations of the cell membrane that are thought to play an 
important role in cell surface signaling and intracellular lipid 
transport [2]. Since its discovery a decade age, caveolin-1 has 
been shown to play a role in the regulation of the signal trans-
duction pathway in various endothelial cells and epithelial cells 
[3]. Caveolins are major constituents of caveolae [4]. Of the three 
isoforms of caveolin (caveolin-1, -2, and -3), caveolin-1 has been 
characterized extensively and shown to interact through its scaf-
fold domain with caveolae-associated signal proteins. The func-
tional roles of caveolin-1 are beginning to emerge with the study 
of caveolin-1 knockout mice. Mice lacking caveolin-1 also lack 
caveolae in the bladder and exhibit several urological disorders, 
including decreased detrusor contractility on stimulation with 
carbachol [5,6]. 
  Previous experiments have focused on the expression of ca-
veolin in the detrusor muscle of the urinary bladder. No studies 
to date, however, have investigated the combined changes in 
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expression of caveolin-1 in the urinary bladder or the function-
al activity of these proteins in response to hormonal alterations. 
The purpose of the present study, therefore, was to investigate 
the effect of estrogen on the expression of caveolin-1 in the uri-
nary bladders of rats, with a focus on suburothelial microvascu-
lar expressing caveolin-1.
MATERIALS AND METHODS
Experimental Model
Female Sprague-Dawley rats (12 weeks old, 230-240 g, n=90) 
were divided into three groups: a control group (n=30), a group 
that underwent bilateral ovariectomy (Ovx, n=30), and a group 
that underwent bilateral ovariectomy plus subcutaneous injec-
tion with 17β-estradiol (Ovx+Est, n=30; Sigma-Aldrich Co., St. 
Louis, MO, USA). The control group underwent a sham opera-
tion. The Ovx group underwent a bilateral ovariectomy and was 
treated with an oil vehicle. The Ovx+Est group underwent a bi-
lateral ovariectomy, which was followed by daily treatment with 
subcutaneous injections of estradiol (50 mg/kg/day) for 7 days 
after ovariectomy. All experimental animals were fed a standard 
diet up until the day before the experiment. Four weeks after 
ovariectomy and 3 weeks after hormonal replacement, animals 
with an estrous cycle confirmed via a vaginal smear were pre-
medicated with xylazine (2.2 mg/kg intramuscularly) and anes-
thetized with a zolazepam/tiletamine cocktail (4.4 mg/kg intra-
muscularly). The study was approved by the Ethics Committee 
of the Chonnam National University Medical School. 
Cystometrogram
Four weeks after the operation, rats (n=10 in each group) were 
anesthetized with a subcutaneous injection of 1.2 g/kg urethane. 
A suprapubic midline incision was performed to expose the 
bladder, a transvesical catheter with a fire-flared tip (polyethyl-
ene catheter-50) was inserted into the dome of the bladder and 
secured with a ligature, and the abdomen was closed. The cath-
eter was connected to a pressure transducer and syringe pump 
via a 3-way stopcock to record intravesical pressure and to in-
fuse saline into the bladder. After the bladder was emptied, cys-
tometry was performed with saline infused at a rate of 0.04 mL/
min. The contraction pressure and contraction interval were 
recorded.
Western Blot 
All minced tissues were homogenized in ice-cold isolation solu-
tion with a Tissumizer homogenizer (Teledyne Tekmar, Mason, 
OH, USA). Tissues were homogenized with five bursts of five 
strokes of a micro-sawtooth generator. Tissue homogenates (n= 
10 in each group, 50 μg of protein) were separated by 12% sodi-
um dodecyl sulfate-polyacrylamide gel electrophoresis and trans-
ferred to polyvinylidene fluoride membranes (Amersham Phar-
macia Biotech, Buckinghamshire, UK). The blots were then wash-
ed with tris-buffered saline Tween-20 (10 mM Tris-HCl, pH 7.6; 
150 mM NaCl; and 0.05% Tween-20). The membrane was block-
ed with 5% skim milk for 1 hour and incubated with the appro-
priate primary antibody. Monoclonal mouse antibodies for ca-
veolin-1 (1:2,000; Chemicon, Ramona, CA, USA) and a poly-
clonal rabbit antibody against glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH) (1:4,000; Cell Signaling Technology 
Inc., Danvers, MA, USA) were used. The membrane was then 
washed, and caveolin-1 and GAPDH were detected with goat 
anti-mouse-IgG and goat anti-rabbit-IgG conjugated to horse-
radish peroxidase, respectively. The antibodies were incubated 
at 4˚C. The bands were visualized by enhanced chemilumines-
cence (Amersham Pharmacia Biotech). GAPDH was used as an 
internal control. Densitometry analysis was performed with a 
Studio Star Scanner with the use of National Institutes of Heal  th 
image V1-57 software.
Immunofluorescence Staining 
The tissue sections (n=10 in each group, 10 sections in each 
tissue) were rinsed in phosphate-buffered saline (PBS) and then 
treated with normal chicken serum for 30 minutes to block non-
specific binding. After being washed in PBS, the sections were 
incubated with antibodies for caveolin-1 (Chemicon) in PBS 
for 12 to 14 hours at 4˚C. Immunoreactivity for caveolin-1 was 
detected with the use of Alexa Fluor 488 chicken anti-mouse 
IgG (H+L; Invitrogen, Carlsbad, CA, USA). Tissues were mount-
ed with the use of mounting solution containing 4ʹ-6-diamidi-
no-2-phenylindole. For a negative control, tissues were prepared 
in a similar manner, except that caveolin-1 was omitted from 
the incubation solution. Tissues were examined with an LSM 
510 confocal microscope (Carl Zeiss, Seoul, Korea) with an ex-
citation wavelength appropriate for Alexa Fluor (405 nm) and 
Alexa Fluor (488 nm). Final images were constructed with the 
use of LSM Image Examiner software. 
Statistical Analysis 
The results are expressed as means±standard deviations; how-
ever, the data for the cystometric parameters are expressed as www.einj.org    15
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means±standard errors of the mean. Analysis of variance was 
used to test the null hypothesis that there would be no differ-
ences in the mean expression levels between the three groups. 
Differences were considered significant at P<0.05.
RESULTS
All of the animals survived for 4 weeks after surgery. Body weight 
was significantly higher in the Ovx group (366±9.7 g) than in 
the control group (263±12.1 g). Treatment of ovariectomized 
animals with 17β-estradiol reduced the body weight to the con-
trol level (264±11.3) (P<0.05). No significant differences in bla-
dder weight were observed between the groups. 
Effect of Estrogen on the Cystometric Parameters 
On cystometrograms performed 4 weeks after the operation, the 
contraction interval was significantly lower in the Ovx group 
(3.0±0.3 minute) than in the control group (5.6±0.5 minute) 
but was higher after estrogen treatment (9.2±0.4 minute) (P< 
0.05). Conversely, the average contraction pressure was higher 
in the Ovx group (26.4±0.48 mmHg) than in the control group 
(21.8±0.37 mmHg) but was lower after estrogen treatment (23.9 
±0.76 mmHg) (P<0.05) (Fig. 1). 
Effect of Estrogen on the Expression of Caveolin -1 
The expression of caveolin-1 was easily detected and was ex-
pressed in capillaries, venules, and arterioles in the subepithelial 
layer (Fig. 2). Immunofluorescence showed that, in terms of the 
cellular patterns of labeling, the expression of caveolin-1 in the 
control group was similar to that in the Ovx and Ovx+Est groups 
(Fig. 2). Western blot analysis showed 22-kDa bands correspon-
ding to caveolin-1 protein (Fig. 3). Caveolin-1 protein was rec-
ognized in all groups. Caveolin-1 protein expression decreased 
significantly after ovariectomy. However, the expression of this 
protein was restored to the control level after treatment with 
17β-estradiol (P<0.05; Fig. 3). 
DISCUSSION
This study showed an altered expression of caveolin-1 in the 
bladder after ovariectomy and estrogen replacement in the uri-
nary bladders of female rats. Four weeks after surgery, cysto-
metric results showed that the voiding interval was shorter and 
the voiding pressure was higher in the bladders of ovariecto-
mized rats than in the controls and returned to the normal con-
trols value after the rats were treated with estrogen. The immu-
nohistochemical study showed that the localization of caveo-
lin-1 in the urinary bladders was detected in the capillaries, ve-
nules, and arterioles of the subepithelial layers. These results 
provide evidence that estrogen deprivation induces bladder in-
stability, and caveolin-1 may play a role in the bladder dysfunc-
tion induced by hormonal changes in females. To our knowl-
Fig. 1. Representative urodynamic profiles of three groups of rats: a control group (Con), a group that underwent bilateral ovariecto-
my (Ovx), and a group that underwent bilateral ovariectomy followed by subcutaneous injections of 17β-estradiol (Ovx + Est). (A) 
The contraction interval in the Ovx group was significantly shorter than that in the control group (
a)P<0.05) and was restored to the 
control value after estrogen treatment (
b)P<0.05). (B) Note the increased peak pressures with each voiding contraction in the Ovx 
group and recovery to the control value in the Ovx + Est group. The lower panels denote the means±standard deviations of 10 experi-
ments for each condition determined by cystometrogram. 
a)P<0.05 vs. Con. 
b)P<0.05 vs. Ovx.
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edge, this is the first study to show the possible occurrence of 
signaling in the suburothelial microvasculature, via caveolin-1, 
in an ovariectomized rat model in which bladder dysfunction 
was induced. 
  Urinary tracts are sensitive to female sex steroids. Many stud-
ies have shown that ovariectomy and estrogen administration 
induce pronounced alterations in lower urinary tract function 
[7]. Ovariectomy results in atrophy of the bladder mucosa, de-
creased smooth muscle mass of the detrusor, decreased bladder 
compliance, and decreased detrusor contractility [8].
  Traditionally, the urothelium has been considered to be a sim-
ple passive barrier between the urinary tract and urine. Recent-
ly, however, the role of the urothelium has changed and it is now 
understood to be a responsive organ capable of sensing a vari-
ety of signals from the urinary bladder [1].
  Evidence suggests that the urothelium can mediate water and 
solute transport under certain conditions in some animals [9,10]. 
Many studies have shown that urinary bladder epithelium con-
tains a sodium transporter [11], which has been described as an 
epithelial sodium channel (ENaC) [12]. ENaC has been known 
to be responsible for salt and fluid transport across the epithelia 
of many tissues. Araki et al. [13] investigated the role of ENaC 
in bladder dysfunction in male patients with clinically detected 
bladder outlet obstruction. They reported that the expression of 
ENaC was significantly greater in the bladders of these patients 
than in the bladders of a control group and that ENaC expres-
sion correlated with the patients’ storage symptom scores. 
  Caveolae were discovered more than 50 years ago and were 
described as 50-100-nm subcellular structures occurring in cap-
Fig. 2. Immunofluorescence labeling for caveolin-1 in the uri-
nary bladders of three groups of rats: a control (Con) group, a 
group that underwent bilateral ovariectomy (Ovx), and a group 
that underwent bilateral ovariectomy followed by subcutaneous 
injections of 17β-estradiol (Ovx+Est). Caveolin-1 expression 
(green) was noted throughout the capillaries, arterioles, and ve-
nules. Immunofluorescence showed that, in terms of the cellular 
patterns of labeling, the expression of caveolin-1 in the Con 
group was similar to that in the Ovx and Ovx+Est groups. The 
horizontal scale bar at the bottom left of each panel indicates the 
magnification power. DAPI, 4’,6- diamidino-2-phenylindole; 
DIC, differential interference contrast.
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Fig. 3. Immunoblotting for caveolin-1 in urinary bladder tissue 
from three groups of rats: a control (Con) group, a group that 
underwent bilateral ovariectomy (Ovx), and a group that un-
derwent bilateral ovariectomy followed by subcutaneous injec-
tions of 17β-estradiol (Ovx+Est). The anti-caveolin-1 antibod-
ies recognize the 22-kDa bands. The anti-glyceraldehyde 3- 
phosphate dehydrogenase (GAPDH) antibody recognizes the 
42-kDa band. The expression of caveolin-1 protein was signifi-
cantly lower in the Ovx group. However, this expression was re-
stored to the control level after treatment with 17β-es  tradiol in 
the Ovx+Est group. The lower panels denote the means 
±standard deviations of the 10 experiments for each condition, 
as determined by densitometry relative to GAPDH. 
a)P<0.05 vs. 
Con. 
b)P<0.05 vs. Ovx.
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illary endothelial cell [14]. Caveolae are plasma membrane in-
vaginations that play a role in signaling [15]. Several important 
cellular processes-such as regulation of lipid transport, choles-
terol homeostasis, endocytosis, and transcytosis in endothelial 
and epithelial cells-have been attributed to these microdomains 
[15]. Caveolin is essential for the formation of caveolae. The ca-
veolin protein family consists of three isoforms (caveolin-1, ca-
veolin-2, and caveolin-3), each of which has a specific expres-
sion pattern in particular cell types. Endothelial cells and fibro-
blasts express high levels of caveolin-1 and caveolin-2, whereas 
striated and cardiac muscles express mostly cavelin-3 [16,17]. 
Mice lacking caveolin-1 also lack caveolae in the bladder and 
exhibit several urologic disorders, including decreased detrusor 
contractility on stimulation with carbachol [5,6] which is some-
what contrary result in terms of bladder contractility related 
with caveolin compared to our study result. Genetic ablation of 
caveolae was found to be associated with a 70% decrease in ace-
tylcholine release from bladder nerve terminals [5]. It has been 
reported that aging and pregnancy are associated with a reduc-
tion in caveolae in the urinary bladder [18,19]. Furthermore, a 
few caveolae can be detected in hypertrophied bladder smooth 
muscle induced by bladder outlet obstruction, which highlights 
the dynamic nature of caveolae in the urinary bladder. Howev-
er, the functional significance of these structures in relation to 
the physiology of the micturition response and voiding function 
had not been fully understood until now. More recently, Cristo-
faro et al. [20] reported that caveolin has a central role in the 
regulation of G-protein-coupled signaling pathways in smooth 
muscle contraction of the bladder. In a recent study of the influ-
ence of hormones on the expression of caveolin-1 in the urinary 
bladders of rats, Zhu et al. [21] reported that estrogen replace-
ment increased the amount of caveolae and caveolin-1 protein 
in the urinary bladder.
  However, no studies have yet investigated the expression of 
caveolin-1 in the suburothelial microvascular endothelial cells 
of the urinary bladder or the changes in the functional activity 
of these proteins in response to changes in sex hormones. In the 
present study, the expression of caveolin-1 in the urinary blad-
der was significantly affected by ovariectomy and estrogen re-
placement and was associated with the improvement and re-
covery of cystometric parameters. These findings suggest that 
caveolin-1 is influenced by the bladder dysfunction induced by 
hormonal alterations. One possible reason for this influence on 
caveolin-1 expression is the location of caveolin-1, i.e., the mi-
crovasculature is highly dependent on hormonal alterations. A 
decreased blood supply in the urinary bladder has been report-
ed after estrogen deprivation. Our results suggest that ovariec-
tomy may lead to a significant down-regulation of caveolin-1 
expression in the urinary bladder of rats, which is presumptive 
evidence that caveolin-1 is involved in the lower urinary tract 
symptoms induced by hormonal alterations, probably via mod-
ifications in specific cellular transmission and signaling path-
ways. A limitation of our study was that the precise functional 
activity of caveolin-1 was not fully elucidated. However, we did 
show a change in caveolin-1 expression in the urinary bladders 
of ovariectomized rats and the possible role of caveolin-1 in the 
overactivity of the detrusor muscle related to hormonal altera-
tions in the urinary bladders of rats. Additional studies are need-
ed to investigate the expression and localization of all members 
of the caveolin family in the urinary bladder and their related 
functional role in the underlying mechanisms of bladder patho-
physiology and dysfunction. 
  In conclusion, this study showed that detrusor overactivity 
induced by estrogen deprivation causes a significant decrease in 
the expression of caveolin-1 in the urinary bladders of female 
rats. This finding suggests that the caveoln-1 isoform might 
change the signal activity in the bladder and might have a func-
tional role in the detrusor overactivity that occurs in association 
with hormonal alterations.
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